Older adults: Should the paradigm shift from standard therapy?

Best Practice & Research Clinical Haematology - Tập 21 - Trang 61-66 - 2008
Elihu H. Estey1
1Section of Acute Leukemia and Myelodysplastic Syndrome, Division of Cancer Medicine, MD Anderson Cancer Center, Box 428, 1515 Holcombe Boulevard, Houston, TX 77030, USA

Tài liệu tham khảo

Beran, 2004, FLT3 mutation and response to intensive chemotherapy in young adult and elderly patients with normal karyotype, Leukemia Research, 28, 547, 10.1016/j.leukres.2003.09.016

Kantarjian, 2006, Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome, Cancer, 106, 1090, 10.1002/cncr.21723

Estey, 1989, Prediction of survival during induction therapy in patients with newly diagnosed acute myeloblastic leukemia, Leukemia, 3, 257

Anderson, 2002, Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study, Blood, 100, 3869, 10.1182/blood-2001-12-0354

Appelbaum, 2006, The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations, British Journal of Haematology, 135, 165, 10.1111/j.1365-2141.2006.06276.x

Rowe, 2004, A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group, Blood, 103, 479, 10.1182/blood-2003-05-1686

Tsimberidou, 2006, Prognostic significance of ß-2 microglobulin levels in acute myeloid leukemia: analysis of 1293 patients, Blood, 108, 240a, 10.1182/blood.V108.11.802.802

Bataille, 1984, Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment–a prospective study of 160 patients, Blood, 63, 468, 10.1182/blood.V63.2.468.468

Giles, 2003, A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression, British Journal of Haematology, 121, 578, 10.1046/j.1365-2141.2003.04306.x

Albitar, 2007, Levels of soluble HLA-I and beta2 M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy, Leukemia, 21, 480, 10.1038/sj.leu.2404506

Thông tin
Thông tin xuất bản

Best Practice & Research Clinical Haematology

Tập 21

61-66

Thông tin tác giả